Last updated: 2026-09-06 02:54:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Satellos Bioscience Inc. (MSLE) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $9.10, with a market capitalization of $192.01M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.44 to $13.39. This page covers its latest market performance, valuation, price trends and company information.
$192.01M | |
$9.13 | |
$13.39 | |
$5.44 | |
$9.08 | |
25.48K | |
-- | |
-- | |
$13.39 | |
$5.44 | |
-- | |
-- |
Satellos Bioscience Inc. (MSLE) last closed at $9.08 as of 2026-09-04 23:31:00, unchanged from the previous close of $9.08.
During the latest regular trading session, MSLE traded between $5.44 and $13.39, with a volume of 25.48K shares. The closing price was near the middle and near the middle of its 52-week range.
Over the past seven days, Satellos Bioscience Inc. (MSLE) moved from $8.78 to $9.10, representing a gain of 3.69% ($0.32).
The stock traded between $9.01 and $9.24 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 21.13 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 46.1%
MSLE is currently trading at $9.10, placing it 46.1% of the way from its 52-week low of $5.44 to its 52-week high of $13.39. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
| Employees | 21 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Satellos Bioscience Inc. (MSLE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.